Increased insulin resistance and beta cell activity in patients with Crohn's disease.
about
Inflammation Meets Metabolic Disease: Gut Feeling Mediated by GLP-1Genetic association of apolipoprotein E polymorphisms with inflammatory bowel diseaseDextran sulfate sodium inhibits alanine synthesis in Caco-2 cells.Metabolic syndrome frequency in inflammatory bowel diseases.Impaired beta cell function is present in nondiabetic rheumatoid arthritis patientsSerum Concentrations of Insulin, Ghrelin, Adiponectin, Leptin, Leptin Receptor and Lipocalin-2 in Children with Celiac Disease Who Do and Do Not Adhere to a Gluten-Free Diet.Carotid intima-media thickness in patients with inflammatory bowel disease: a systematic review.MicroRNAs and Inflammation in Colorectal Cancer.Are adipocytokines inflammatory or metabolic mediators in patients with inflammatory bowel disease?Endocrine and metabolic manifestations in inflammatory bowel diseaseAn overview of lipid abnormalities in patients with inflammatory bowel diseaseCirculating leptin and adiponectin and their relation to glucose metabolism in children with Crohn's disease and ulcerative colitis.Is inflammatory bowel disease a risk factor for early atherosclerosis?Effects of dietary fat profile on gut permeability and microbiota and their relationships with metabolic changes in mice.Elevated platelet expression of CD36 may contribute to increased risk of thrombo-embolism in active inflammatory bowel disease.Glucose Metabolism Parameters and Post-Prandial GLP-1 and GLP-2 Release Largely Vary in Several Distinct Situations: a Controlled Comparison Among Individuals with Crohn's Disease and Individuals with Obesity Before and After Bariatric Surgery.Sharing of Genes and Pathways Across Complex Phenotypes: A Multilevel Genome-Wide Analysis.Favorable Effect of Anti-TNF Therapy on Insulin Sensitivity in Nonobese, Nondiabetic Patients with Inflammatory Bowel Disease.Early atherosclerosis in ulcerative colitis: cross-sectional case-control study.
P2860
Q26752511-55029CFF-C0F6-429A-AEAC-4582DEEF5336Q34986020-A43E43C6-A458-41BF-8C24-A60520211EEEQ35079222-A629AE96-6E1F-4417-BCC9-08D0404C5F6CQ35564312-79449D3D-EC5E-48B3-B177-B9F9899CA894Q36903389-8FC6205E-D456-441A-88D3-16D315C2A544Q37066380-9C276569-3465-4791-9EBF-521404D002BCQ38083042-4BAA5E87-455B-48B2-82D2-E582D357CEB0Q38940592-2B303896-690C-42EE-A4F1-1F09109693FAQ42370720-59BDBE39-3B5C-48D0-A7A3-0D999056C93DQ42406756-72B89248-3721-4B1C-81A5-32CA8B58F16FQ42406811-95513BB2-BF87-42E7-BC03-45A609AACF5AQ45346768-D4128C8A-5C42-4581-B5B0-CC1D3449C606Q46034527-87F094FA-EBFF-4AF1-973F-F0FBB163A867Q46718112-EC9F4DE3-13DC-4F24-8E50-D7290E0FC307Q47991595-F298925D-2A24-4015-A835-C9471AEA2BB6Q47992176-3987DC15-58D4-4121-898C-A01F2CCAA57DQ48155517-75EBE4DB-CE29-4375-8222-441502958428Q51244473-5FF568DB-115E-4A0E-BECA-0D9939F34097Q51294837-2B8F56A8-A57C-4BEA-A330-498CAD7360C0
P2860
Increased insulin resistance and beta cell activity in patients with Crohn's disease.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Increased insulin resistance and beta cell activity in patients with Crohn's disease.
@en
Increased insulin resistance and beta cell activity in patients with Crohn's disease.
@nl
type
label
Increased insulin resistance and beta cell activity in patients with Crohn's disease.
@en
Increased insulin resistance and beta cell activity in patients with Crohn's disease.
@nl
prefLabel
Increased insulin resistance and beta cell activity in patients with Crohn's disease.
@en
Increased insulin resistance and beta cell activity in patients with Crohn's disease.
@nl
P2093
P2860
P1476
Increased insulin resistance and beta cell activity in patients with Crohn's disease.
@en
P2093
Alexander Hartmann
L Cornelius Bollheimer
Nicole Bregenzer
Tilo Andus
Ulrike Strauch
P2860
P356
10.1097/01.MIB.0000195975.97673.F5
P577
2006-01-01T00:00:00Z